https://www.selleckchem.com/pr....oducts/AR-42-HDAC-42
Promising activities were confirmed in the resistant cyst form of the amoeba and in additional clinical Acanthamoeba strains, increasing their therapeutic potential. #link# Mechanism-of-action studies revealed that these compounds produce apoptosis through reactive oxygen species (ROS)-mediated mitochondrial damage. These chemical families show promise for further optimization to produce effective antiacanthamoebal drugs.Shorter, more potent regimens are needed for tuberculosis. The nitroimidazole pretomanid was recently approved
Like
Comment
Share
